With recent advancements made in thoracic oncology, the management of non-small cell lung cancer (NSCLC) is evolving rapidly. While chemotherapy, immunotherapy, targeted therapy, molecular testing, and radiotherapy continue to play a large role in the management of lung cancer, especially in later–stage treatment, surgical therapy remains an essential component of lung cancer treatment in both early-stage lung cancer as well as in some cases of metastatic disease.  

 Dr. Jeffrey Velotta from Kaiser Permanente joined GO2’s June 2024 Lung Cancer Living Room to discuss surgical options for people with lung cancer. He also explained why options for surgery will depend on the tumor’s location, size, and stage.

Speakers:    
  • Jeffrey B. Velotta, MD, Thoracic Surgery, Kaiser Permanente, Oakland, CA and Clinical Assistant Professor, Department of Surgery, UCSF  
  • Danielle Hicks, Chief Patient Officer, GO2 for Lung Cancer    
Discussed in this episode:    
  • Learning about surgical treatment options can help guide you in having an informed discussion with your doctor. 
  • Lung cancer staging is an important step in the diagnostic process that can impact your treatment options, including surgery. 
  • The results of your biomarker testing will tell your healthcare team what mutations or changes your cancer might have. These results will guide your team to the best treatment for you.  
  • A multidisciplinary care team is a group of doctors, nurses, and other healthcare professionals who work together to provide high-quality, coordinated care.   
  • Learn more about second opinions and when you might want to seek one.  
  • Stay updated on the latest in lung cancer and treatment through The Magnifying LeNS: Learning New Science Quarterly.

Please join us on August 20 at 5:30 p.m. PT/8:30 p.m. ET for the next Lung Cancer Living Room covering pulmonary care. Join in person at our San Carlos, CA office or watch on YouTube Live.       

For more information on the Living Room, other GO2 for Lung Cancer programs, or support through diagnosis and treatment, please contact GO2’s HelpLine at 1-800-298-2436 or email support@go2.org.